Package 63187-521-30

Brand: bupropion

Generic: bupropion
NDC Package

Package Facts

Identity

Package NDC 63187-521-30
Digits Only 6318752130
Product NDC 63187-521
Product ID 63187-521_001c902a-af30-40fb-bb22-cc18bd8fc94c
Description

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-521-30)

Marketing

Marketing Status
Marketed Since 2018-12-01
Brand bupropion
Generic bupropion
Sample Package No

Linked Drug Pages (1)

bupropion ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "001c902a-af30-40fb-bb22-cc18bd8fc94c", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["47ceb7e1-b2f7-47f8-8b6a-85eea36606b8"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-521-30)", "package_ndc": "63187-521-30", "marketing_start_date": "20181201"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-521-60)", "package_ndc": "63187-521-60", "marketing_start_date": "20181201"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (63187-521-90)", "package_ndc": "63187-521-90", "marketing_start_date": "20181201"}], "brand_name": "bupropion", "product_id": "63187-521_001c902a-af30-40fb-bb22-cc18bd8fc94c", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "63187-521", "generic_name": "bupropion", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA201567", "marketing_category": "ANDA", "marketing_start_date": "20140215", "listing_expiration_date": "20261231"}